PDS Biotechnology Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
PDS Biotechnology Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2018 to Q3 2024.
  • PDS Biotechnology Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 36.8M shares, a 19.1% increase year-over-year.
  • PDS Biotechnology Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 31M shares, a 8.23% increase from 2022.
  • PDS Biotechnology Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 28.6M shares, a 11.7% increase from 2021.
  • PDS Biotechnology Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 25.6M shares, a 52.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 36.8M +5.9M +19.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 36.7M +5.89M +19.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 34.8M +4.39M +14.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 31M +2.35M +8.23% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 30.9M +2.45M +8.62% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 30.8M +2.35M +8.26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 30.4M +4.27M +16.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 28.6M +3M +11.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 28.5M +32.8K +0.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 28.5M +5.29M +22.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 26.2M +3.9M +17.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 25.6M +8.85M +52.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 28.4M +9.46M +49.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 23.2M +7.8M +50.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 22.3M +11.9M +116% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 16.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 19M +13.7M +261% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 15.4M +10.2M +197% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 10.3M +6.57M +175% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 5.25M +1.9M +56.8% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 5.18M +1.84M +55% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 3.75M +649K +20.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 3.35M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 3.34M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 3.1M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.